GK: 1st Quarter 2022 Portfolio Review

Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost. Returns less than one year are not annualized. For the fund’s most recent standardized and month-end performance, please click www.advisorshares.com/etfs/gk.


The first three months of the year were one of the worst first quarters on record. There were a few reasons for the turmoil.

First, inflation rose to a four-decade high, continuing a trend that began during the latter half of last year. Prices on everything from clothes to eggs to gas spiked, weighing on consumer confidence and causing investors to worry about the strength of the economy.

Secondly, the Fed raised rates for the first time since December 2018, and with policymakers having telegraphed more tightening ahead, traders are now betting the next two Fed meetings will each produce half-point hikes. Surging rates mean companies have higher borrowing costs, which is bad news for growth stocks – including many big tech names – whose valuations are based on future earnings.

Third, Russia’s invasion of Ukraine further exacerbated inflation. Western nations targeted Russian oil exports with sanctions, while Ukraine is one of the world’s largest grain producers. That one-two punch caused already escalating gas and food prices around the globe to climb even more.

The Worst Is Behind Us

Due to all this strife, the S&P declined by 4.6% during the first three months of 2022, while the tech-heavy NASDAQ Composite was down nearly 9%. The carnage would have been far worse had stocks not staged a comeback during the final weeks of the quarter, when the S&P rallied nearly 12% from March 14 – 28.

As painful as elevated rates may be in the interim, it is the best approach to ensure the longer-term health of the economy, and all told, we believe the worst is behind us. Indeed, while stocks may not finish the year in the black, markets should be able to withstand the ups and downs, thanks to a strong labor market, resilient consumer spending and relatively strong corporate earnings.

Not Immune, But Still Optimistic

The AdvisorShares Gerber Kawasaki ETF (GK) was not immune to some of the obstacles cited above that caused the broad-based declines. Many of our technology and climate-focused investments took a beating.

Still, we have never been as optimistic about the future of our top holdings – Tesla, Microsoft, Apple and Nvidia – as we are today. In our opinion, all are solid, mature and high-growth companies with enormous upside. Even so, we have made adjustments within the fund that reflect the reality of today’s environment.

For example, rate hikes have made some of our real estate holdings unattractive, so we have pared them in favor of financials such as Morgan Stanley and Silicon Valley Bank. Also, we shed consumer discretionary exposure to add industrials, including John Deere and Northup Grumman.

And finally, we trimmed our Global X Lithium & Battery Tech ETF position in light of increased political interference in business and intensifying Covid-19 protocols in China, which produces an overwhelming majority of the world’s lithium batteries.

Thanks to these moves, and others, we believe the fund is in a great position to recover and produce outsize gains once markets stabilize. That should happen once inflation cools and the Fed taps the breaks on increases, which should occur about six months to a year from now. Until then, expect continued volatility.

Top Holdings

Ticker Security Description Portfolio Weight %

As of 03.31.2022. Subject to change. Cash is not included. 



Ross Gerber
Gerber Kawasaki, President and CEO
AdvisorShares Gerber Kawasaki ETF (GK) Portfolio Manager

Past Manager Commentary



The S&P 500 Index is a broad-based, unmanaged measurement of changes in stock market conditions based on the average of 500 widely held common stocks. One cannot invest directly in an index.


Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained by visiting www.advisorshares.com. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, distributor.

There is no guarantee that the Fund will achieve its investment objective. An investment in the Fund is subject to risk, including the possible loss of principal amount invested. Investing in mid and small capitalization companies may be riskier and more volatile than large cap companies. Because it intends to invest in value stocks, the Fund could suffer losses or produce poor results relative to other funds, even in a rising market, if the Sub-Advisor’s assessment of a company’s value or prospects for exceeding earnings expectations or market conditions is incorrect. Other Fund risks include market risk, equity risk, large cap risk, liquidity risk and trading risk. Please see prospectus for details regarding risk. 

Investing involves risk including possible loss of principal. The Sub-Advisor’s judgment about the markets, the economy, or companies may not anticipate actual market movements, economic conditions or company performance, and these factors may affect the return on your investment. When models and data prove to be incorrect or incomplete, any decisions made in reliance thereon expose the Fund to potential risks. In addition, the use of predictive models has inherent risk. Because predictive models are usually constructed based on historical data supplied by third parties, the success of relying on such models may depend heavily on the accuracy and reliability of the supplied historical data. The prices of growth stocks are based largely on projections of the issuer’s future earnings and revenues. If a company’s earnings or revenues fall short of expectations, its stock price may fall dramatically.

Companies involved in the cannabis industry face competition, may have limited access to banks, limited resources due to litigation and are dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to cultivate, possess or distribute cannabis. The possession and use of cannabis, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments.

The value of stocks of technology companies tend to be more volatile than the overall market and are vulnerable to rapid changes in technology, rapid product obsolescence, the loss of patent, copyright and trademark protections and government regulation and competition. The expansion of online gambling (both regulated and unregulated), including the award of additional licenses or expansion or relocation of existing gambling companies, and competition from other leisure and entertainment activities, could impact these companies’ finances. Companies within the biotech industry invest heavily in research and development, which may not lead to commercially successful products.

Diversification does not guarantee favorable returns. While the fund invests across multiple thematic trends it is considered a “non-diversified fund” under federal law, the Fund may invest a greater percentage of its assets in a particular issuer and hold a smaller number of portfolios securities.

Shares are bought and sold at market price (closing price) not NAV and are not individually redeemed from the Fund. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined), and do not represent the return you would receive if you traded at other times.

Holdings and allocations are subject to risks and to change.

The views in this commentary are those of the portfolio manager and may not reflect his views on the date this material is distributed or anytime thereafter. These views are intended to assist shareholders in understanding their investments and do not constitute investment advice.